Classification of Imbalanced Tumor Gene Expression Data Based on Weighted Gaussian Process

Author(s):  
Ruirui Ji ◽  
Meng Zhao ◽  
Yi Wu
2019 ◽  
Vol 31 (12) ◽  
pp. 2292-2303 ◽  
Author(s):  
Xuesong Wang ◽  
Jian Liu ◽  
Yuhu Cheng ◽  
Aiping Liu ◽  
Enhong Chen

eLife ◽  
2017 ◽  
Vol 6 ◽  
Author(s):  
Julien Racle ◽  
Kaat de Jonge ◽  
Petra Baumgaertner ◽  
Daniel E Speiser ◽  
David Gfeller

Immune cells infiltrating tumors can have important impact on tumor progression and response to therapy. We present an efficient algorithm to simultaneously estimate the fraction of cancer and immune cell types from bulk tumor gene expression data. Our method integrates novel gene expression profiles from each major non-malignant cell type found in tumors, renormalization based on cell-type-specific mRNA content, and the ability to consider uncharacterized and possibly highly variable cell types. Feasibility is demonstrated by validation with flow cytometry, immunohistochemistry and single-cell RNA-Seq analyses of human melanoma and colorectal tumor specimens. Altogether, our work not only improves accuracy but also broadens the scope of absolute cell fraction predictions from tumor gene expression data, and provides a unique novel experimental benchmark for immunogenomics analyses in cancer research (http://epic.gfellerlab.org).


Oncotarget ◽  
2017 ◽  
Vol 8 (65) ◽  
pp. 109646-109660 ◽  
Author(s):  
Jian Liu ◽  
Xuesong Wang ◽  
Yuhu Cheng ◽  
Lin Zhang

2017 ◽  
Author(s):  
Julien Racle ◽  
Kaat de Jonge ◽  
Petra Baumgaertner ◽  
Daniel E. Speiser ◽  
David Gfeller

AbstractImmune cells infiltrating tumors can have important impact on tumor progression and response to therapy. We present an efficient algorithm to simultaneously estimate the fraction of cancer and immune cell types from bulk tumor gene expression data. Our method integrates novel gene expression profiles from each major non-malignant cell type found in tumors, renormalization based on cell-type specific mRNA content, and the ability to consider uncharacterized and possibly highly variable cell types. Feasibility is demonstrated by validation with flow cytometry, immunohistochemistry and single-cell RNA-Seq analyses of human melanoma and colorectal tumor specimens. Altogether, our work not only improves accuracy but also broadens the scope of absolute cell fraction predictions from tumor gene expression data, and provides a unique novel experimental benchmark for immunogenomics analyses in cancer research.


Sign in / Sign up

Export Citation Format

Share Document